Summary of Significant Accounting Policies - Schedule of Common Stock Equivalents Excluded from the Calculation of Diluted Net Loss Per Share (Details) - shares |
12 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
|
Anti-dilutive securities | |||
Total shares excluded from diluted net loss per share applicable to common stockholders | 14,334,911 | 12,193,144 | 7,852,873 |
Stock options | |||
Anti-dilutive securities | |||
Total shares excluded from diluted net loss per share applicable to common stockholders | 6,657,268 | 5,468,605 | 4,618,421 |
Unvested Restricted Stock Units | |||
Anti-dilutive securities | |||
Total shares excluded from diluted net loss per share applicable to common stockholders | 2,687,487 | 1,734,383 | 1,116,358 |
Warrants | |||
Anti-dilutive securities | |||
Total shares excluded from diluted net loss per share applicable to common stockholders | 4,990,156 | 4,990,156 | 2,118,094 |